Efficacy and Tolerability of Delayed-release Dimethyl Fumarate in Black, Hispanic, and Asian Patients with Relapsing-Remitting Multiple Sclerosis: Post Hoc Integrated Analysis of DEFINE and CONFIRM

INTRODUCTION: Clinical course and treatment response may vary according to race/ethnicity in multiple sclerosis (MS) patients. Delayed-release dimethyl fumarate (DMF; also known as gastro-resistant DMF) demonstrated significant efficacy and a favorable benefit–risk profile in relapsing-remitting MS...

Descripción completa

Detalles Bibliográficos
Autores principales: Fox, Robert J., Gold, Ralf, Phillips, J. Theodore, Okwuokenye, Macaulay, Zhang, Annie, Marantz, Jing L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700899/
https://www.ncbi.nlm.nih.gov/pubmed/28770420
http://dx.doi.org/10.1007/s40120-017-0077-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700899/
https://www.ncbi.nlm.nih.gov/pubmed/28770420
http://dx.doi.org/10.1007/s40120-017-0077-5

Ejemplares similares